This study evaluates the SUNTRAC tool in guiding initial skin cancer risk stratification among renal transplant patients in New Zealand. Higher retrospectively applied SUNTRAC grades in 219 patients were associated with higher incidence of skin cancer, supporting the tool’s effectiveness in guiding initial skin cancer risk stratification in this population.
MoleMax Systems, a division of Macquarie Medical Systems, specialises in the development and production of dermatoscopic hardware and software, including dermatoscopes and the MoleMax Dermoscopy Software. These integrated solutions are designed for early clinical imaging sessions, analysis and comparisons of skin cancer, providing dermatologists with advanced tools for high-resolution imaging and analysis of skin lesions to improve patient outcomes.
Subscribe To The MoleMax Newsletter
